In addition, inhibition of AChE, responsible for the breakdown of acetylcholine in the neural synapse, is a possible strategy for treatment of AD, which is characterized by a decline in cognitive function and mental atrophy. The gene discussed is ACHE; the disease is Alzheimer disease.